MikeTrendsTrends right now

search

Health Star Rating

Trends

  1. 1
    Blue Shield of California Promise Plan Gets 4 Stars in NCQA Medicaid Ratings▼Blue Shield of California Promise Health Plan Earns 4 out of 5 Stars in NCQA’s 2026 Medicaid Health Plan Ratings for Third Consecutive Year✉newsHealth3 d ago

    Blue Shield of California Promise Health Plan has earned a 4 out of 5 star rating in the National Committee for Quality Assurance's 2026 Medicaid Health Plan Ratings, marking the third consecutive year it has achieved this score. The rating reflects the plan's measured performance on quality and member care standards for its Medicaid customers in California.

  2. 2
    Alignment Health sues CMS again over Medicare star ratings▼Alignment Health again sues CMS over Medicare Advantage star ratings✉newsHealth3 d ago

    Insurer Alignment Health has filed a new lawsuit against the Centers for Medicare and Medicaid Services over its Medicare Advantage star ratings. The quality scores directly affect bonus payments to insurers, and Alignment is disputing how CMS calculated its ratings. The case adds to ongoing legal challenges by health insurers against the agency's star ratings methodology.

  3. 3
    Alignment Health sues over 2027 Medicare star ratings▼Alignment Health sues over 2027 star ratings✉newsHealth4 d ago

    Alignment Health, the California-based Medicare Advantage insurer, has filed a lawsuit challenging its 2027 star ratings from the Centers for Medicare and Medicaid Services. The ratings determine bonus payments to insurers, making the case financially significant for the company. The news, reported by Modern Healthcare, has drawn attention within the health insurance industry.

  4. 4
    Clover Health Stock Seen as Reasonable Despite New Five-Star Ratings●Clover Health (CLOV) Stock Looks Reasonable Despite New 5 Star Ratings✉newsHealth6 d ago

    Clover Health shares are being described as reasonably valued even after the company earned new five-star quality ratings. The insurer, known for its Medicare Advantage plans, saw analysts weigh whether the ratings lift the investment case or are already priced in. Coverage so far is limited to a single assessment, with little wider commentary available yet.